Abstract
Monoclonal antibodies (MAbs) to chemokine receptors are providing remarkable insight into the roles these receptors play in basal leukocyte trafficking for immune response and surveillance as well as cell specific recruitment to sites of inflammation. This latter role in particular has established chemokine receptors as attractive targets for novel antiinflammatory drug discovery. The large number of chemokines and receptors, the complex nature of their distinct and overlapping binding specificities, and the differential expression of receptors on leukocytes may provide the opportunity to develop therapeutics that selectively target subsets of leukocytes and thus avoid the broad immunosuppressive actions of most currently available antiinflammatory drugs (1). The major obstacle in the path to such therapeutics is unlikely to be the discovery and development of potent and selective chemokine receptor antagonists, inasmuch as seven transmembrane spanning G-protein couple receptors have proven to be a most successful class of drug targets (2). However, sorting through the various and complex functions mediated by a multitude chemokine receptor-ligand interactions in order to ascertain which receptor(s) is responsible for site specific recruitment of cells during initiation, progression, and maintenance of a particular disease will be a formidable task.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ponath P. D. (1998) Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS. Exp. Opin. Invest. Drugs 7, 1–18.
Stadel J. M., Wilson S., and Bergsma D. J. (1997) Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery. Trends Pharm. Science 18, 430–437.
Qin S., Rottman J. B., Myers P., Kassam N., Weinblatt M., Loetscher M., et al. (1998) The chemokine receptors CXCR3 and CCR5 mark a subset of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101, 746–754.
Ponath P. D., Qin S., Post T. W., Wang J., Wu L., Gerard N. P., et al. (1996) Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183, 2437–2448.
Heath H., Qin S., Rao P., Wu L., LaRosa G., Kassam N., et al. (1997) Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99, 178–184.
Ying S., Robinson D. S., Meng Q., Rottman J. B., Kennedy R., Ringler D. J. (1997) Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperreactivity and predominant colocalization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur. J. Immunol. 27, 3507–3516.
Loetscher P., Seitz M., Baggiolini M., and Moser B. (1996) Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184, 569–577.
Penton-Rol G., Polentarutti N., Luini W., Borsatti A., Mancinelli R., Sica A., et al. (1998) Selective inhibition of the chemokine receptor CCR2 in human mono-cytes by INF-γ. J. Immunol. 160, 3869–3873.
Sallusto F., Lenig D., Mackay C., and Lanzavecchia A. (1998) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187, 875–883.
Foxman E. F., Campbell J. J., and Butcher E. C. (1997) Multistep navigation and the combinatorial control of leukocyte chemotaxis. J. CellBiol. 139, 1349–1360.
Jones S. A., Wolf M., Qin S., Mackay C. R., and Baggiolini M. (1996) Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phosolipase D are activated through IL-8R1 but not IL-8R2. Proc. Natl. Acad. Sci. USA 93, 6682–6686.
Hammond M. E. W., Lapointe G. R., Feucht P. H., Hilt S., Gallegos C. A., Gordon C. A., et al. (1995) IL-8 induces neutrophil chemotaxis predominately via type IL-8 receptors. J. Immunol. 155, 1428–1433.
Chuntharapai A. and Kim K. J. (1995) Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J. Immunol. 155, 2587–2594.
Zagorski J. and Wahl S. M. (1997) Inhibition of acute peritoneal inflammation in rats by a cytokine induced neutrophil chemoattractant receptor antagonist. J. Immunol. 159, 1059–1062.
Gong J. H., Ratkay L. G., Waterfield J. D., and Clark-Lewis I. (1997) An antagonist of monocyte chemoattractant protein 1 (MCP-1-inhibits arthritis in the MRL-lpr mouse model. J. Exp. Med. 186, 131–137.
Lukacs N. W., Strieter R. M., Shaklee C. L., Chensue S. W., and Kunkel S. L. (1995) Macrophage inflammatory protein-1 alpha influences eosinophil recruitment in antigen-specific airway inflammation. Eur. J. Immunol. 25, 245–251.
Broaddus V. C., Boylan A. M., Hoeffel J. M., Kim K. J., Sadick M., Chuntharapai A., and Hebert C. A. (1994) Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J. Immunol. 152, 2960–2967.
Rand M. L., Warren J. S., Mansour M. K., Newman W., and Ringler D. J. (1996) Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1. Am. J. Path. 148, 855–864.
VanOtteren G. M., Strieter R. M., Kunkel S. L., Paine R. R., Greenberger M. J., Danforth J. M., et al. (1995) Compartmentalized expression of RANTES in a murine model of endotoxemia. J. Immunol. 154, 1900–1908.
Harada A., Sekido N., Akahoshi T., Wada T., Mukaida N., and Matsushima K. (1994) Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol. 5, 559–564.
Baggiolini M., Dewald B., and Moser B. (1997) Human chemokines: an update. Ann. Rev. Immunol. 15, 675–705.
Weber M., Uguccioni M., Baggiolini M., Clark Lewis I., and Dahinden C. A. (1996) Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J. Exp. Med. 183, 681–685.
Gong J. H., Uguccioni M., Dewald B., Baggiolini M., and Clark-Lewis I. (1996) RANTES and MCP-3 antagonists bind multiple chemokine receptors. J. Biol. Chem. 271, 10,521–10,527.
Koch A. E., Polverini P. J., Kunkel S. L., Harlow L. A., DiPietro L. A., Elner V. M., et al. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798–1801.
Strieter R. M., Kunkel S. L., Arenberg D. A., Burdick M. D., and Polverini P. J. (1995) Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem. Biophys. Res. Commun. 210, 51–57.
Cao Y., Chen C., Weatherbee J. A., Tsang M., and Folkman J. (1995) gro-beta, a-C-X-C-chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J. Exp. Med. 182, 2069–2077.
Graham G. J., Wright E. G., Hewick R., Wolpe S. D., Wilkie N. M., Donaldson D., et al. (1990) Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344, 442–444.
Nagasawa T., Hirota S., Tachibana K., Takaura N., Nishikawa S., Kitamura Y., et al. (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635–638.
Sarris A. H., Broxmeyer H. E., Wirthmueller U., Karasavvas N., Cooper S., Lu L., et al. (1993) Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors. J. Exp. Med. 178, 1127–1132.
Karpus W. J. and Kennedy K. J. (1997) MIP-1 alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukoc. Biol. 62, 681–687.
Van Snick J., Houssiau F., Proost P., Van Damme J., and Renauld J. C. (1996) I-309/T cell activation gene 3 chemokine protects murine T cell lymphomas against dexamethasone induced apoptosis. J. Immunol. 157, 2570–2576.
Cook D. N., Beck M. A., Coffman T. M., Kirby S. L., Sheridan J. F., Pragnell I. B., and Smithies O. (1995) Requirement of MlP-1α for an inflammatory response to viral infection. Science 269, 1583–1585.
Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C., and Lusso P. (1995) Identification of RANTES, MlP-lα, and MIP-1 β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811–1815.
Xia M., Qin S., McNamara M., Mackay C., and Hyman B. J. (1997) Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer’s disease. Am. J. Path. 150, 1267–1274.
Gupta S. K., Lysko P. G., Pillarisetti K., Ohlstei E., and Stadel J. M. (1998) Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem. 273, 4282–4287.
Chuntharapai A., Lee J., Burnier J., Wood W. I., Hebert C., and Kim K. J. (1994) Neutralizing monoclonal antibodies to human IL-8 receptor A map to the NH2-terminal region of the receptor. J. Immunol. 152, 1783–1789.
Chuntharapai A., Lee J., Hebert C. A., and Kim K. J. (1994) Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J. Immunol. 153, 5682–5688.
Endres M. J., Clapham P. R., Marsh M., Ahuja M., Turner J. D., McKnight A., Thomas J. F., Stoebenau-Haggarty B., Choe S., Vance P. J., Wells T. N. C., Power C. A., Sutterwala S. S., Doms R. W., Landau N. R., and Hoxie J. A. (1996) CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745–756.
Forster R., Emrich T., Kremmer E., and Lipp M. (1994) Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood 84, 830–840.
Frade J. M. R., Llorente M., Mellado M., Alcami J., Gutierrez-Ramos J. C., Zaballos A., del Real G., and Martinez-A. C. (1997) The amino-terminal domain of the CCR2 chemokine receptor acts as a coreceptor for HIV-1 infection. J. Clin. Invest. 100, 497–502.
Wu L., Paxton W. A., Kassam N., Ruffing N., Rottman J. B., Sulliva N., et al. (1997) CCR5 levels and expression pattern correlate with infectability by mac-rophage-tropic HIV-1, in vitro. J. Exp. Med 185, 1681–1691.
Wu L., LaRosa G., Kassa N., Gordon C. J., Heath H., Ruffing N., et al. (1997) Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186, 1373–1381.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Ponath, P.D., Kassam, N., Qin, S. (2000). Monoclonal Antibodies to Chemokine Receptors. In: Proudfoot, A.E.I., Wells, T.N.C., Power, C.A. (eds) Chemokine Protocols. Methods in Molecular Biology, vol 138. Humana Press. https://doi.org/10.1385/1-59259-058-6:231
Download citation
DOI: https://doi.org/10.1385/1-59259-058-6:231
Publisher Name: Humana Press
Print ISBN: 978-0-89603-722-9
Online ISBN: 978-1-59259-058-2
eBook Packages: Springer Protocols